サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1299772

レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Red Biotechnology Market with COVID-19 Impact Analysis, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size,Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 341 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
レッドバイオテクノロジー市場：製品タイプ別、用途別、エンドユーザー別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 341 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

レッドバイオテクノロジー市場規模は2022年に3,514億960万米ドルとなり、2023年から2030年にかけてCAGR 6.2%で拡大

レッドバイオテクノロジー市場- 市場力学：

レッドバイオテクノロジーは、医療分野の不可欠な側面として登場し、臨床試験、遺伝子治療、調査、診断に顕著な応用があります。さらに、生命を脅かす病気を治療するためのさまざまな新薬の製造や発明、遺伝子工学などの利点もあります。このような要因により、レッドバイオテクノロジー市場は成長を続けています。しかし、色相製造の費用や臨床試験の後期段階での薬剤の失敗率の増加は、市場の成長を抑制する要因です。さらに、発酵技術はヘルスケア分野やライフサイエンス分野で活用されており、近い将来の市場成長を促進すると思われます。

さらに、市場企業による開発研究投資の増加や、臨床試験における新薬のパイプラインの充実、製品制裁のエスカレートなど、増大する要件に対応するための新型促進装置の設置は、レッドバイオテクノロジー市場の収益成長の主な要因となっています。パンデミックCOVID-19は、レッドバイオテクノロジー市場に若干マイナスの影響を与えています。医薬品開発企業は新たな経営上の問題に直面しており、新薬の承認とともに臨床試験にも何らかの影響が予想されます。薬物調査のための臨床試験を実施している市場関係者は、患者登録の減速を経験しており、病院がCOVID-19の患者を優先するため、一時的に試験施設を閉鎖せざるを得なくなっています。

レッドバイオテクノロジー市場-セグメンテーション分析：

世界のレッドバイオテクノロジー市場は、製品タイプ、用途、エンドユーザー、地域に基づいてセグメント化されます。

モノクローナル抗体、ポリクローナル抗体、遺伝子組換え、タンパク質ワクチン、細胞ベースの免疫療法製品、遺伝子治療製品、細胞治療製品、組織工学製品、幹細胞、細胞培養、ウイルスベクター、酵素、キット・試薬、動物モデル、分子診断、その他。モノクローナル抗体分野が最大市場を占めると予想されます。モノクローナル抗体は、その有効性と安全性からCOVID-19緩和の代替薬となっています。

同市場は用途によって、薬理ゲノミクス、バイオ医薬品生産、遺伝子治療、遺伝子検査の4つに分類されます。遺伝子治療分野は、予測期間中も優位性を維持しそうです。希少疾患の原因となる様々な遺伝性疾患を治療するための治療薬の改良のためです。

市場はエンドユーザーによって、研究機関、CMO＆CRO、バイオ医薬品産業、その他の3つに分類されます。バイオ医薬品業界が最大の市場シェアを占めると予想されます。研究開発努力の高まりが、バイオ医薬品産業分野の成長の主な要因となっています。

レッドバイオテクノロジー市場-競合情勢：

企業は、顧客基盤を拡大するために、収益性の高い分野でバイオテクノロジーを確立する他社との戦略的提携に注力しています。さらに、市場プレーヤーは、製品の拡大、M&A、戦略的提携、パートナーシップ、新製品の発売、製品の差別化など、市場シェアを拡大するための戦略を追求しています。さらに、個別化医療に対する需要の高まり、遺伝子研究の進歩、バイオテクノロジー製品の研究開発への巨額の投資は、市場の成長を促進すると思われます。例えば、2022年8月、Myovant社は、中等度から重度の子宮内膜症に伴う疼痛を治療するためのrelugolix配合錠（Myfembree；Myovant Sciences社とPfizer社）のFDA承認取得を発表しました。

研究の主な特徴

この調査レポートは、レッドバイオテクノロジー市場の市場規模、CAGR、2022年を基準年とした推定・予測（2023-2030年）を提供しています。

この調査レポートは、さまざまなセグメント/国にわたる潜在的な成長機会を解明し、レッドバイオテクノロジー市場の魅力的な投資提案マトリクスを解説しています。

全体的なレポートでは、新規投資機会、既存企業が直面する課題、レッドバイオテクノロジー市場で持続するための成長要因を特定しています。

レッドバイオテクノロジー市場規模、予測、CAGR、市場力学に対するCOVID-19の影響は、調査範囲の下で詳細に議論されています。COVID後のレッドバイオテクノロジー市場に関する詳細な洞察もカバーします。

本レポートのユーザーにレッドバイオテクノロジー市場の包括的な見解を提供するために、レッドバイオテクノロジー市場の競合情勢と主要イノベーター分析も含めています。

本調査では、市場規模、成長率、魅力度に基づいてすべての業界セグメントをベンチマークする成長見通しマッピング分析を網羅しています。

本レポートは、主要な市場参入企業を特集した詳細な企業プロファイルを提供しており、レッドバイオテクノロジー市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立ちます。

さらに、本レポートは、世界レベルだけでなく地域レベルで市場に関与する主要参入企業の重要な買収＆合併、提携＆ジョイントベンチャー、新発売、研究開発、地域展開も明らかにしています。

レッドバイオテクノロジーの世界市場レポートは主に、サプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 レッドバイオテクノロジー市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 レッドバイオテクノロジーの主要な市場動向

  • レッドバイオテクノロジー市場促進要因
  • レッドバイオテクノロジー市場抑制要因
  • レッドバイオテクノロジー市場機会
  • レッドバイオテクノロジー市場の将来動向

第4章 レッドバイオテクノロジー産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 レッドバイオテクノロジー市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 レッドバイオテクノロジー市場情勢

  • レッドバイオテクノロジー市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 レッドバイオテクノロジー市場-製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • モノクローナル抗体
    • ポリクローナル抗体
    • 組換え
    • プロテインワクチン
    • 細胞ベースの免疫療法製品
    • 遺伝子治療製品
    • 細胞治療製品
    • 組織工学的に加工された製品
    • 幹細胞
    • 細胞培養
    • ウイルスベクター
    • 酵素
    • キットと試薬
    • 動物モデル
    • 分子診断学

第8章 その他レッドバイオテクノロジー市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 薬理ゲノミクス
    • バイオ医薬品の生産
    • 遺伝子治療
    • 遺伝子検査

第9章 レッドバイオテクノロジー市場- エンドユーザー別

  • 概要
    • エンドユーザー別のセグメントシェア分析
    • 調査機関
    • CMOとCRO
    • バイオ医薬品産業

第10章 レッドバイオテクノロジー市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米のレッドバイオテクノロジー主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州のレッドバイオテクノロジー主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域のレッドバイオテクノロジー主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカのレッドバイオテクノロジー主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカのレッドバイオテクノロジー主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- レッドバイオテクノロジー産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Takeda Pharmaceutical Company Ltd.
    • Amgen Inc.
    • Hoffmann-La Roche, Ltd.
    • Merck KGaA
    • Regeneron Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • Biogen Inc.
    • AstraZeneca Plc.
    • Gilead Sciences, Inc.
    • CELGENE CORPORATION
    • Regeneron Pharmaceuticals, Inc.
    • Gilead Sciences, Inc.

第12章 アナリストの全方位的展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Red Biotechnology Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Red Biotechnology Market, by Product Type2018-2030 (USD Million)
  • TABLE Red Biotechnology Market: ApplicationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Red Biotechnology Market, by Application2018-2030 (USD Million)
  • TABLE Red Biotechnology Market: Regional snapshot (2022)
  • TABLE Red Biotechnology Market: End-User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Red Biotechnology Market, by End-User 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Red Biotechnology Market, by Region 2018-2030 (USD Million)
  • TABLE North America Red Biotechnology Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Red Biotechnology Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Red Biotechnology Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Red Biotechnology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Europe Red Biotechnology Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Red Biotechnology Market, by Product Type, 2018-2030 (USD Million)
  • TABLE EuropeRed Biotechnology Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Red Biotechnology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Red Biotechnology Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Red Biotechnology Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Red Biotechnology Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Red Biotechnology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Latin America Red Biotechnology Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Red Biotechnology Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Red Biotechnology Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Red Biotechnology Market, by End-User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Red Biotechnology Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Red Biotechnology Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Red Biotechnology Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Red Biotechnology Market, by End-User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Red Biotechnology Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Product Type segment market share analysis, 2022&2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022&2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-User segment market share analysis, 2022&2030
  • FIGURE End-User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Red Biotechnology Market share and leading players, 2022
  • FIGURE Europe Red Biotechnology Market share and leading players, 2022
  • FIGURE Asia Pacific Red Biotechnology Market share and leading players, 2022
  • FIGURE Latin America Red Biotechnology Market share and leading players, 2022
  • FIGURE Middle East and Africa Red Biotechnology Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Red Biotechnology Market share analysis by country, 2022
  • FIGURE Germany Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE NetherlandsRed Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE SwedenRed Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE PolandRed Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Red Biotechnology Market share analysis by country, 2022
  • FIGURE India Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Red Biotechnology Market share analysis by country, 2022
  • FIGURE Brazil Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE ColombiaRed Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Red Biotechnology Market share analysis by country, 2022
  • FIGURE Saudi Arabia Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Red Biotechnology Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1362

REPORT HIGHLIGHT

Red Biotechnology Market size was valued at USD 351,409.6 Million in 2022, expanding at a CAGR of 6.2% from 2023 to 2030.

Red biotechnology is a process that uses in various organisms to improve healthcare and built immunity in disease-fighting. This modern technology is used in the medical field. Additionally, it is not only applicable in the pharmaceutical industry but also the medical industry as it helps to improve lifestyle quality and reduce human suffering. Moreover, it has been utilized in several fields such as diagnostics, research, gene therapy, and clinical trials. The major advantages of red biotechnology include product development and genetic engineering belonging to new medicines for life-threatening diseases treatment.

Red Biotechnology Market - Market Dynamics:

Red biotechnology come up as an essential aspect of the medical field and has noticeable applications in clinical trials, gene therapy, research, and diagnostics. Additionally, it offers other advantages such as the manufacturing and invention of different novel drugs to treat life-threatening diseases and genetic engineering. Owing to such factors flourish the red biotechnology market growth. However, hue manufacturing charges and an increase in the failure rate of drugs in the clinical trials' later stages are such factors that may restrain the market growth. Moreover, fermentation technology is utilized in the healthcare sector and life science, which will drive market growth in the near future.

Furthermore, rising investment in development & research by market players and the emplacement of new-fangled facilitates for addressing augmented requirements, in clinical trials robust pipeline of new drugs, and escalating product sanctions are major drivers in the growth of red biotechnology market revenue. The pandemic COVID-19 has had a slightly negative impact on the red biotechnology market. Drug developers are facing new operational issues and anticipate some influence on clinical trials along with the new drug approvals. Market players that are running clinical trials for the drug investigation are experiencing a slowdown in patient enrollment and they have been forced to close trial sites temporarily, as hospitals prioritize the patient of COVID-19.

Red Biotechnology Market - Segmentation Analysis:

The global red biotechnology market is segmented on the basis of product type, application, end-user, and region.

The market is divided into fifteen categories based on product type: monoclonal antibodies, polyclonal antibodies, recombinant, proteins vaccines, cell-based immunotherapy products, gene therapy products, cell therapy products, tissue-engineered products, stem cells, cell culture, viral vectors, enzymes, kits and reagents, animal models, molecular diagnostics, and others. The monoclonal antibodies sector is expected to dominate the largest market. The monoclonal antibodies are alternatives for COVID-19 mitigation due to effectiveness and safety.

The market is divided into four categories based on application: pharmacogenomics, biopharmaceutical production, gene therapy, and genetic testing. The gene therapy sector is likely to maintain its dominance during the forecast period. For the betterment of therapeutics to treat various genetic disorders responsible for rare sicknesses.

The market is divided into three categories based on end-user: research institutes, CMOs & CROs, biopharmaceutical industries, and others. The biopharmaceutical industry sector is expected to hold the largest market share. Rising R&D efforts are a major factor for the biopharmaceutical industries segment growth.

Red Biotechnology Market-Competitive Landscape:

Companies are focusing on strategic partnerships with other companies of biotechnology establish in profitable areas to grow their customer base. Additionally, market players are pursuing strategies to increase their market share including product expansion, mergers & acquisitions, strategic collaborations, and partnerships, launching new products, and product differentiation. Moreover, rising demand for personalized medicine, increase advances in genetic research, and huge investment in R&D of biotechnology products will propel the market growth. For instance, in August 2022, Myovant announced, FDA-approved relugolix combination tablets (Myfembree; Myovant Sciences and Pfizer) to treat moderate-to-severe endometriosis-associated pain.

Key features of the study:

This proposed research study on red biotechnology market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for red biotechnology market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the red biotechnology market.

Impact of COVID-19 on red biotechnology market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on red biotechnology market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the red biotechnology market, we have also included competitive landscape and key innovator analysis for the red biotechnology market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the red biotechnology market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global red biotechnology market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RED BIOTECHNOLOGY MARKET KEY PLAYERS

  • Takeda Pharmaceutical Company Ltd.
  • Amgen Inc.
  • Hoffmann-La Roche, Ltd.
  • Merck KGaA
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Biogen Inc.
  • AstraZeneca Plc.
  • Gilead Sciences, Inc.
  • CELGENE CORPORATION
  • Regeneron Pharmaceuticals, Inc.
  • Gilead Sciences, Inc.

GLOBAL RED BIOTECHNOLOGY MARKET, BY PRODUCT TYPE

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant
  • Proteins Vaccines
  • Cell-Based Immunotherapy Products
  • Gene Therapy Products
  • Cell Therapy Products
  • Tissue-Engineered Products
  • Stem Cells
  • Cell Culture
  • Viral Vector
  • Enzymes
  • Kits and Reagents
  • Animal models
  • Molecular diagnostics
  • Others

GLOBAL RED BIOTECHNOLOGY MARKET, BY APPLICATION

  • Pharmacogenomics
  • Biopharmaceutical Production
  • Gene Therapy
  • Genetic Testing

GLOBAL RED BIOTECHNOLOGY MARKET, BY END-USER

  • Research Institutes
  • CMOs & CROs
  • Biopharmaceutical Industries
  • Others

GLOBAL RED BIOTECHNOLOGY MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Red Biotechnology Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Red Biotechnology Market Snippet by Product Type
    • 2.1.2. Red Biotechnology Market Snippet by Application
    • 2.1.3. Red Biotechnology Market Snippet by End-User
    • 2.1.4. Red Biotechnology Market Snippet by Country
    • 2.1.5. Red Biotechnology Market Snippet by Region
  • 2.2. Competitive Insights

3. Red Biotechnology Key Market Trends

  • 3.1. Red Biotechnology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Red Biotechnology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Red Biotechnology Market Opportunities
  • 3.4. Red Biotechnology Market Future Trends

4. Red Biotechnology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Red Biotechnology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Red Biotechnology Market Landscape

  • 6.1. Red Biotechnology Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Red Biotechnology Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Monoclonal Antibodies
    • 7.1.3. Polyclonal Antibodies
    • 7.1.4. Recombinant
    • 7.1.5. Proteins Vaccines
    • 7.1.6. Cell-Based Immunotherapy Products
    • 7.1.7. Gene Therapy Products
    • 7.1.8. Cell Therapy Products
    • 7.1.9. Tissue-Engineered Products
    • 7.1.10. Stem Cells
    • 7.1.11. Cell Culture
    • 7.1.12. Viral Vector
    • 7.1.13. Enzymes
    • 7.1.14. Kits and Reagents
    • 7.1.15. Animal models
    • 7.1.16. Molecular diagnostics

8. OthersRed Biotechnology Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Pharmacogenomics
    • 8.1.3. Biopharmaceutical Production
    • 8.1.4. Gene Therapy
    • 8.1.5. Genetic Testing

9. Red Biotechnology Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2022&2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. CMOs & CROs
    • 9.1.4. Biopharmaceutical Industries

10. Others Red Biotechnology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Red Biotechnology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Red Biotechnology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Red Biotechnology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Red Biotechnology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Red Biotechnology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Red Biotechnology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Takeda Pharmaceutical Company Ltd.
    • 11.2.2. Amgen Inc.
    • 11.2.3. Hoffmann-La Roche, Ltd.
    • 11.2.4. Merck KGaA
    • 11.2.5. Regeneron Pharmaceuticals, Inc.
    • 11.2.6. Pfizer, Inc.
    • 11.2.7. Biogen Inc.
    • 11.2.8. AstraZeneca Plc.
    • 11.2.9. Gilead Sciences, Inc.
    • 11.2.10. CELGENE CORPORATION
    • 11.2.11. Regeneron Pharmaceuticals, Inc.
    • 11.2.12. Gilead Sciences, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us